These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10467321)

  • 1. Human herpes virus 8 (HHV8) serology in allogeneic bone marrow transplant recipients.
    Rosenzwajg M; Fery N; Bons V; Damaj G; Gluckman E; Gluckman J
    Bone Marrow Transplant; 1999 Aug; 24(4):351-4. PubMed ID: 10467321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human herpesvirus 8 DNA in serum during seroconversion in allogeneic bone marrow transplant recipients.
    Gentile G; Capobianchi A; Volpi A; Palù G; Pica F; Calistri A; Biasolo MA; Martino P
    J Natl Cancer Inst; 2005 Jul; 97(13):1008-11. PubMed ID: 15998954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion.
    Keever-Taylor CA; Bredeson C; Loberiza FR; Casper JT; Lawton C; Rizzo D; Burns WH; Margolis DA; Vesole DH; Horowitz M; Zhang MJ; Juckett M; Drobyski WR
    Biol Blood Marrow Transplant; 2001; 7(11):620-30. PubMed ID: 11760150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretransplantation prevalence of human herpes virus 8 antibodies in kidney donors and recipients in Athens, Greece.
    Panayiotakopoulos GD; Papaconstantinou I; Mavroyianni D; Kostakis A; Kordossis T
    Transplant Proc; 2005 Dec; 37(10):4180-2. PubMed ID: 16387072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to human herpesvirus 8 latent and lytic antigens in blood donors and potential high-risk groups in Sweden: variable frequencies found in a multicenter serological study.
    Enbom M; Sheldon J; Lennette E; Schulz T; Ablashi DV; Neipel F; Biberfeld P; Carlberg H; Ljungman P; Nilsson A; Söderström T; Wadström J; Linde A
    J Med Virol; 2000 Dec; 62(4):498-504. PubMed ID: 11074479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NK cell activity controls human herpesvirus 8 latent infection and is restored upon highly active antiretroviral therapy in AIDS patients with regressing Kaposi's sarcoma.
    Sirianni MC; Vincenzi L; Topino S; Giovannetti A; Mazzetta F; Libi F; Scaramuzzi D; Andreoni M; Pinter E; Baccarini S; Rezza G; Monini P; Ensoli B
    Eur J Immunol; 2002 Oct; 32(10):2711-20. PubMed ID: 12355422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for cytomegalovirus, hepatitis B and C virus reactivation after bone marrow transplantation.
    Zekri AR; Mohamed WS; Samra MA; Sherif GM; El-Shehaby AM; El-Sayed MH
    Transpl Immunol; 2004 Dec; 13(4):305-11. PubMed ID: 15589744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Seroprevalence and risk factors of human herpes virus 8 infection in Central-East Tunisia].
    Hannachi N; Ben Fredj N; Samoud S; Ferjani A; Khlif A; Boughammoura L; Soussi S; Aouni M; Skouri H; Boukadida J
    Pathol Biol (Paris); 2012 Oct; 60(5):282-6. PubMed ID: 22115818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of related donor peripheral blood and bone marrow transplants: importance of late-onset chronic graft-versus-host disease and infections.
    Anderson D; DeFor T; Burns L; McGlave P; Miller J; Wagner J; Weisdorf D
    Biol Blood Marrow Transplant; 2003 Jan; 9(1):52-9. PubMed ID: 12533742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asymmetrical transmission of human herpesvirus 8 among spouses of patients with Kaposi sarcoma.
    Dupuy A; Schulz T; Chevret S; Agbalika F; Pellet C; Janier M; Dupin N; Vérola O; Calvo F; Lebbé C
    Br J Dermatol; 2009 Mar; 160(3):540-5. PubMed ID: 19077076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatal disseminated Kaposi's sarcoma following human herpesvirus 8 primary infections in liver-transplant recipients.
    Marcelin AG; Roque-Afonso AM; Hurtova M; Dupin N; Tulliez M; Sebagh M; Arkoub ZA; Guettier C; Samuel D; Calvez V; Dussaix E
    Liver Transpl; 2004 Feb; 10(2):295-300. PubMed ID: 14762870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early predictors of transplant-related mortality (TRM) after allogeneic bone marrow transplants (BMT): blood urea nitrogen (BUN) and bilirubin.
    Bacigalupo A; Oneto R; Bruno B; Soracco M; Lamparelli T; Gualandi F; Occhini D; Raiola A; Mordini N; Berisso G; Bregante S; Dini G; Lombardi A; Lint MV; Brand R
    Bone Marrow Transplant; 1999 Sep; 24(6):653-9. PubMed ID: 10490732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary BK virus (BKV) infection due to possible BKV transmission during bone marrow transplantation is not the major cause of hemorrhagic cystitis in transplanted children.
    Bogdanovic G; Priftakis P; Taemmeraes B; Gustafsson A; Flaegstad T; Winiarski J; Dalianis T
    Pediatr Transplant; 1998 Nov; 2(4):288-93. PubMed ID: 10084731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum HHV8 DNA and Tat antibodies in Kaposi's sarcoma patients with and without HIV-1 infection.
    Massambu C; Pyakurel P; Kaaya E; Enbom M; Urassa W; Demirhan I; Loewer J; Linde A; Chandra A; Heiden T; Doerr HW; Chandra P; Biberfeld P
    Anticancer Res; 2003; 23(3B):2389-95. PubMed ID: 12894519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-centre experience with allogeneic bone marrow transplantation for acute lymphoblastic leukaemia in childhood: similar survival after matched-related and matched-unrelated donor transplants.
    Al-Kasim FA; Thornley I; Rolland M; Lau W; Tsang R; Freedman MH; Saunders EF; Calderwood S; Doyle JJ
    Br J Haematol; 2002 Feb; 116(2):483-90. PubMed ID: 11841456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation.
    Meisel R; Enczmann J; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Wernet P; Göbel U; Laws HJ; Dilloo D
    Klin Padiatr; 2005; 217(3):135-41. PubMed ID: 15858704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transplantation of haematopoietic stem cells derived from cord blood, bone marrow or peripheral blood: a single centre matched-pair analysis in a heterogeneous risk population.
    Schönberger S; Niehues T; Meisel R; Bernbeck B; Laws HJ; Kögler G; Enzmann J; Wernet P; Göbel U; Dilloo D
    Klin Padiatr; 2004; 216(6):356-63. PubMed ID: 15565551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor/recipient mixed chimerism does not predict graft failure in children with beta-thalassemia given an allogeneic cord blood transplant from an HLA-identical sibling.
    Lisini D; Zecca M; Giorgiani G; Montagna D; Cristantielli R; Labirio M; Grignani P; Previderè C; Di Cesare-Merlone A; Amendola G; Bergami E; Mastronuzzi A; Maccario R; Locatelli F
    Haematologica; 2008 Dec; 93(12):1859-67. PubMed ID: 18945748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human herpesvirus 6 viremia in bone marrow transplant recipients: clinical features and risk factors.
    Yoshikawa T; Asano Y; Ihira M; Suzuki K; Ohashi M; Suga S; Kudo K; Horibe K; Kojima S; Kato K; Matsuyama T; Nishiyama Y
    J Infect Dis; 2002 Apr; 185(7):847-53. PubMed ID: 11920307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung function, pulmonary complications, and mortality after allogeneic blood and marrow transplantation in children.
    Kaya Z; Weiner DJ; Yilmaz D; Rowan J; Goyal RK
    Biol Blood Marrow Transplant; 2009 Jul; 15(7):817-26. PubMed ID: 19539213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.